CIPLA.NS
Cash Flow
Cipla Ltd. · Healthcare
Cash Flow · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-09-23 02:08
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | N/A | N/A | ₹3,325.90 Cr. | ₹3,237.65 Cr. | ₹4,133.91 Cr. | ₹5,004.98 Cr. | ₹3,940.02 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | N/A | N/A | ₹-1,871.88 Cr. | ₹-2,388.51 Cr. | ₹-2,988.03 Cr. | ₹-3,691.14 Cr. | ₹-2,326.13 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | N/A | N/A | ₹-1,599.79 Cr. | ₹-958.29 Cr. | ₹-1,200.43 Cr. | ₹-1,292.79 Cr. | ₹-1,233.65 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | N/A | N/A | ₹13.45 Cr. | ₹12.37 Cr. | ₹5.56 Cr. | ₹9.26 Cr. | ₹92.50 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | N/A | N/A | ₹-132.32 Cr. | ₹-96.78 Cr. | ₹-48.99 Cr. | ₹30.31 Cr. | ₹472.74 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | N/A | N/A | ₹790.43 Cr. | ₹658.11 Cr. | ₹561.33 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
| Dividends Paid | N/A | N/A | N/A | N/A | ₹403.35 Cr. | ₹403.50 Cr. | ₹686.17 Cr. | ₹1,049.83 Cr. | ₹1,292.40 Cr. | DividendsPaidClassifiedAsFinancingActivities |
Every figure above is the exact value of the named XBRL element from CIPLA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).